Stockscreener 앱 받기
0.2772
2.08%
-0.0059
시간 외 거래:
.28
0.0028
+1.01%
Curanex Pharmaceuticals Inc 주식(CURX)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Contrasting Curanex Pharmaceuticals (CURX) and The Competition - Defense World
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Nigeria
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation - Investing.com
Curanex Pharmaceuticals (CURX) Competitors and Alternatives 2026 - MarketBeat
Curanex Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Curanex Pharmaceuticals Announces CFO Transition - TradingView — Track All Markets
Curanex Pharmaceuticals Inc Announces Executive Changes - marketscreener.com
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to S&P TMI Index - MarketScreener
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Weekly Research Analysts’ Ratings Updates for Curanex Pharmaceuticals (CURX) - Defense World
Curanex Pharmaceuticals Inc (CURX) is looking forward to a strong quarter - setenews.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Get insights into the top gainers and losers of Wednesday's pre-market session. - Chartmill
Curanex Pharmaceuticals Faces Nasdaq Delisting Warning - MSN
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
Wall Street Zen Downgrades Curanex Pharmaceuticals (NASDAQ:CURX) to Sell - Defense World
Curanex Pharmaceuticals Inc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com
Curanex Pharmaceuticals Inc SEC 10-Q Report - TradingView
Curanex Pharmaceuticals receives Nasdaq notice on minimum bid price requirement - Investing.com Australia
1.24%
0.19%
자본화:
|
볼륨(24시간):